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Background: Variations in circadian genes can impact biological rhythms. Given the rhythm disturbances
that characterize bipolar disorder (BD), genes encoding components of molecular clocks are good can-
didate genes for the illness.
Methods: A family based association analysis of circadian gene single nucleotide polymorphisms (SNPs)
and BD was conducted in Latino pedigrees. 884 individuals from 207 pedigrees (473 BP phenotype and
411 unaffected family members) were genotyped. Family based single marker association testing was
performed. Ancestral haplotypes (SNPs found to be in strong LD deﬁned using conﬁdence intervals) were
also tested for association with BD.
Results: Multiple suggestive associations between circadian gene SNPs and BD were noted. These in-
cluded CSNK1E (rs1534891, p¼0.00689), ARNTL (rs3789327, p¼0.021172), CSNK1D (rs4510078,
p¼0.022801), CLOCK (rs17777927, p¼0.031664). Individually, none of the SNPs were signiﬁcantly as-
sociated with BD after correction for multiple testing. However, a 4-locus CSNK1E haplotype encom-
passing the rs1534891 SNP (Z-score¼2.685, permuted p¼0.0076) and a 3-locus haplotype in ARNTL (Z-
score¼3.269, permuted p¼0.0011) showed a signiﬁcant association with BD.
Limitations: Larger samples are required to conﬁrm these ﬁndings and assess the relationship between
circadian gene SNPs and BD in Latinos.
Conclusions: The results suggest that ARNTL and CSKN1E variants may be associated with BD. Further
studies are warranted to assess the relationships between these genes and BD in Latino populations.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Rhythm disturbances have long been recognized as signiﬁcantB.V. This is an open access article u
. Gonzalez).
conceptualization, data ana-
dered ﬁrst authors.features of bipolar disorder (BD). As such, disturbances of biolo-
gical rhythms have been hypothesized to play a fundamental role
in the etiology of the disorder (Gonzalez, 2014). BD is a complex
trait disorder (Craddock and Sklar, 2013). A substantial amount of
evidence suggests that genetic factors confer a signiﬁcant risk to
the development of BD and possibly to the phenotypic expression
of the illness (Craddock and Sklar, 2013; Kieseppa et al., 2004).
Given that there are now a number of genes known tonder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Sample characteristics of pedigrees by country of origin.
United States Guatemala Costa Rica Mexico
Pedigrees 56 17 39 95
Individuals with BD 122 41 105 205
Affected parents 17 4 10 34
Trios 27 6 35 88
1 parent 1 sibling 37 10 10 51
1 parent 2 siblings 33 9 5 16
1 parent 3 siblings 7 2 24 13
1 parent 4 siblings 1 5 4 3
1 parent 5 siblings – – 5 1
1 parent 6 siblings – 5 7 2
1 parent 7 siblings – – 2 –
1 parent 8 siblings – – 3 –
R. Gonzalez et al. / Journal of Affective Disorders 186 (2015) 367–375368inﬂuence circadian patterns, variations in these circadian genes
may contain variants that are associated with susceptibility to
bipolar disorder.
The precision of the circadian timing system is in large part
dictated by the expression of circadian genes and the interactions
of their protein products (Edery, 2000; Reppert and Weaver, 2002).
Alterations in these core circadian genes can change the expressed
circadian period and phase (Ralph et al., 1990) and disrupt normal
circadian rhythmicity (Herzog et al., 1998).
Circadian gene variants have been associated with BD (Bene-
detti et al., 2004b; Benedetti et al., 2005; Kishi et al., 2008; Kripke
et al., 2009; Lamont et al., 2010; Lee et al., 2010; Mansour et al.,
2009; Mansour et al., 2006; McGrath et al., 2009; Nievergelt et al.,
2006; Pickard et al., 2008; Serretti et al., 2003, 2005; Severino
et al., 2009; Shi et al., 2008; Soria et al., 2010; Szczepankiewicz
et al., 2006) and clinical signatures of the illness (Lamont et al.,
2010). Preliminary studies also suggest that a less robust molecular
clock may be associated with the disorder (Yang et al., 2009). In
addition, emerging literature suggests that certain pharmacologi-
cal treatments (Benedetti et al., 2005; Johansson et al., 2011; Li
et al., 2002; Osland et al., 2011; Padiath et al., 2004) and biologi-
cally based treatments (Benedetti et al., 2004b) for the illness may
exert some of their therapeutic action through molecular clocks.
Preclinical models also suggest physiological relationships be-
tween circadian gene functioning, BD, and pathophysiological
mechanisms previously implicated in the illness (Roybal et al.,
2007).
While there have been studies examining the relationship be-
tween circadian gene markers and BD, to the best of our knowl-
edge none have been conducted in Latino populations. We,
therefore, conducted a family based association study in a Latino
population to examine the relationship between circadian gene
single nucleotide polymorphisms (SNPs) and BD. Hispanics are the
largest and fastest growing ethnic group in the United States, re-
presenting 16 percent of the US population (Ennis et al., 2011).
This decade, the Hispanic population has grown by 43% and in-
dividuals with Mexican origin increased by 54% (Ennis et al., 2011).
Despite this growth, there is a tremendous paucity of psychiatric
genetic research focused on this population. Hispanics are an ad-
mixed population resulting from interbreeding between in-
dividuals from different continental populations, in which ances-
tral genomes have diverged over time due to genetic drift and/or
natural selection (Dries, 2009). The mixture of ancestral genomes
in Hispanics makes genetic studies susceptible to population
stratiﬁcation issues, in which spurious associations of allele fre-
quencies between cases and controls are due to systematic dif-
ferences in ancestry rather than association of genes with disease
state (Freedman et al., 2004). Most investigators have cir-
cumvented population stratiﬁcation issues by focusing their efforts
on more homogenous populations, namely Caucasians of Eur-
opean descent. However, concerns regarding population stratiﬁ-
cation should not lead to exclusion of admixed groups such as
Hispanics, as observed differences in prevalence rates, disease
presentation, and treatment outcomes for BD may be explained by
ethnic speciﬁc genetic variation (Oquendo et al., 2010). We,
therefore, conducted a family based association study in a Latino
population to examine the relationship between circadian gene
single nucleotide polymorphisms (SNPs) and BD, as family based
studies are robust against population stratiﬁcation issues (Horvath
et al., 2001).2. Methods
2.1. Study sample
Study procedures were approved by the institutional review
board at Texas Tech University Health Science Center as well as by
the institutional review boards of all participating research sites.
All subjects signed institutional review board approved consent
forms prior to enrolling in the study. Research was performed in
accordance with the Helsinki Declaration of 1975.
Latino subjects were recruited from the United States (Texas,
New Mexico, and California), Mexico (Mexico City, Monterrey),
Costa Rica (San Jose), and Guatemala (Guatemala City) as part of a
multi-site study to identify genes associated with bipolar disorder
in persons of meso-American Latino ancestry (Gonzalez et al.,
2014). Previous genetic structure analysis has shown that these
populations are closely related, with high levels of admixture
consisting of three major ancestral populations (Caucasian, Native
American, and African) (Campos-Sanchez et al., 2013). Families
recruited for this study were families with presumed multiplex
cases of Bipolar Type I Disorder or Schizoaffective Bipolar Disorder,
with ancestry (at least two of the four grandparents of BD pro-
band) from Mexico or Central America. For the current analysis of
circadian gene variants, we utilized a sample consisting of subjects
from 207 of these pedigrees.
Diagnoses were made according to DSM-IV criteria. A best-es-
timation consensus procedure using the Diagnostic Interview for
Genetic Studies (DIGS), the Family Interview for Genetic Studies
(FIGS), and a review of available psychiatric records was used to
conﬁrm diagnoses as previously described (Gonzalez et al., 2013).
Of the total of 884 individuals included in the present analyses,
473 met best estimation criteria for lifetime diagnosis of either
Bipolar Disorder, Type I or Schizoaffective Disorder, Bipolar Type,
by DSM IV criteria.
2.2. Genotyping
A total of 884 individuals from 207 pedigrees (473 with BD
phenotype: 257 Bipolar Disorder Type I with psychosis, 200 Bi-
polar Disorder Type I without psychosis, 16 Schizoaffective, Bipolar
Type and 411 additional family members) were genotyped for
these analyses of circadian gene variants. For each BD subject, we
genotyped the subject and both parents if DNA was available. If
both parents were not available, we genotyped the BD subject, one
parent, and additional siblings. Table 1 shows the sample char-
acteristics of pedigrees by country of origin.
DNA was isolated from lymphoblastoid cell lines established
and stored for each study participant at the NIMH Center for
Collaborative Genetic Studies. SNPs were genotyped usingTotal (% female) 220 (66.4%) 70 (64.3%) 210 (56.7%) 384 (59.4%)
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BeadExpress System (Illumina Inc., San Diego, CA). Genotyping
was blinded to subject diagnosis and characteristics. The SNP pa-
nel consisted of variants from circadian genes selected from the
literature based on previous association with BD in other studies
(Benedetti et al., 2003, 2004a, 2004b; Mansour et al., 2006, 2009;
McGrath et al., 2009; Nievergelt et al., 2006; Severino et al., 2009;
Shi et al., 2008; Soria et al., 2010; Szczepankiewicz et al., 2006).
These included SNPs in the following genes: Aryl Hydrocarbon
Receptor Nuclear Translocator-Like 1 (ARNTL), Circadian Loco-
motor Output Cycles Kaput (CLOCK), Casein Kinase 1 Epsilon
(CSNK1E), Cryptochrome 1 (CRY1), Cryptochrome 2 (CRY2), Gly-
cogen Synthase Kinase 3-beta (GSK3β), Neuronal PAS Domain
Protein 2 (NPAS2), Nuclear Receptor Subfamily 1, Group D, Mem-
ber 1 (NR1D1), Period 1 (PER1), Period 2 (PER2), Period 3 (PER3),
RAR-Related Orphan Nuclear Receptor Beta (RORβ), and Timeless
(TIM), Casein Kinase 1 Epsilon (CSNK1E), and Peroxisome Pro-
liferator-Activated Receptor Gamma, Coactivator 1 Beta
(PPARGC1B). Additional SNP selection was designed to cover the
circadian genes of interest (ARNTL, CLOCK, CSNK1E, CRY2, GSK3β,
PER2, RORβ, and TIM) and was based on a Tagging SNP approach
(r2Z0.9) using SNPbrowserTM software version 4.0 (Applied Bio-
systems) using a minimum minor allele frequency of 0.1 and was
based on data from CEU, YRI, and CHB HapMap populations.
Genotype data was assessed for quality using the plink soft-
ware. Individuals with 410% missing genotype data and SNPs
with excessive missingness (410%), minor allele frequencies
o0.01, or exhibiting deviations from Hardy–Weinberg Equilibrium
(HWEo0.01) were removed prior to analysis. Genotypes were
checked for Mendelian errors, with inconsistent genotypes set to
missing.2.3. Statistical analysis
Family based single marker and haplotype association testing
was performed using the FBAT ver 2.0.4 software package (Hor-
vath et al., 2001) which is able to test for association using data
from nuclear families, sibships, pedigrees, or any combination
(with or without founder genotypes), is adjusted for population
admixture, and it is not biased due to pedigree relationships or
population. All SNPs were subjected to FBAT analysis in the initial
stage. A second analysis, using haplotypes, was conducted only for
SNPs showing evidence of association in stage 1. Haploview ver-
sion 4.2 (Barrett et al., 2005) was used to visualize LD relationships
between genotyped variants and to deﬁne the LD blocks following
the D' method described by Gabriel et al. (2002). Haplotype ana-
lyses were performed using the Haplotype-Based Association
Testing (HBAT) assessment in the FBAT ver 2.0.4 program (Horvath
et al., 2004). Haplotype speciﬁc and global permuted P-values
were calculated for individual haplotype tests in haplotype FBAT,
assuming an additive genetic model. In order to maximize power
in the statistical analyses, permutation procedures were im-
plemented to calculate the empirical p-values derived from 10,000
permutations.
The power calculations for family designs for binary traits and
multiple family-types were done in PBAT (v3.3) using Monte-Carlo
simulations (Lange et al., 2004) based on actual sample pedigree
structures. Type I error was set at 0.05. The additive inherited
model was assumed using the average minor allele frequency of
0.27 and population prevalence 0.01.3. Results
3.1. Sample characteristics
Four SNPs and 14 individuals were removed for excessive
missingness (40.1). All remaining SNPs (N¼92) passed minor
allele frequency and HWE thresholds (MAF40.01; HWE40.01,
respectively). The total successful genotyping rate in the remaining
individuals was 0.958. After quality control ﬁltering, there were 92
SNP genotypes for 870 individuals (465 BD phenotype, 405 un-
affected relatives). Of these, 341 (39.2%) were male and 529
(60.8%) were female. Within the 207 pedigrees, there were 533
nuclear families consisting of 147 affected offspring with both
parents and 318 affected individuals without both parents (but
with a minimum of 2 ﬁrst degree relatives). The Mendelian error
rate was 5.22E05, with 4 Mendel errors detected in total which
were set to missing. Power calculations by PBAT estimated that the
study had o99% power to detect odd ratios of 2.0 (major effect),
71% power to detect odd ratio of 1.5 (modest effect) and 20%
power to detect odd ratio of 1.2 (low effect).
3.2. Single marker results
Nominal associations between several of the circadian gene
SNPs and BD were noted. These included variants in CSNK1E
(rs1534891, p¼0.00689), ARNTL (rs3789327, p¼0.0212), CSNK1D
(rs4510078, p¼0.0228), and CLOCK (rs17777927, p¼0.0317). In-
dividually, none of the SNPs were signiﬁcantly associated with BD
after correction for multiple testing (critical p¼5.43E4). We then
selected genes with nominal evidence of association in the FBAT
analysis (CSNK1E, ARNTL, and CLOCK), for further haplotype ana-
lysis. CSNK1D was excluded from further analysis, as rs4510078
was the only marker genotyped within the gene.
3.3. Haplotype results
The LD relationships between genotyped variants were deﬁne
following the D' method in Haploview. Haplotype based-associa-
tion test results are shown in Table 2. Three additional SNPs
(rs2075983; rs6001093; rs135757) were found to be in strong LD
with the rs1534891 SNP in CSNK1E (Fig. 1). The whole marker
permutation test of the CSNK1E haploblock was signiﬁcantly as-
sociated with BD (Χ2 sum; P¼5.91103). A speciﬁc 4-locus
CSNK1E haplotype (AAGA) showed a signiﬁcant association with
BD (Z-score¼2.685, permuted P¼7.62103). A second haplo-
type (AGAA) was signiﬁcantly under-transmitted in BD (Z-
score¼2.829, permuted P¼5.45103).
The rs3789327 SNP was part of a 3-locus haploblock
(rs1868049; rs3789327; rs11022778) in the ARNTL gene (Fig. 2).
The global ARNTL haploblock permutation test was signiﬁcantly
associated with BD (Χ2 sum; P¼2.99103). A 3-locus ARNTL
haplotype (GAA) showed a signiﬁcant association with BD (Z-
score¼3.269, permuted P¼1.06103). A second haplotype
(GGA) was signiﬁcantly undertransmitted in BD (Z-score¼2.49,
permuted p¼0.0148).
Nine additional markers (rs10462028; rs1801260; rs3805148;
rs3736544; rs11932595; rs4340844; rs4864542; rs2070062;
rs13132420) were in the same LD block with rs17777927 within
the CLOCK gene (data not shown). No statistically signiﬁcant as-
sociations were noted between CLOCK haplotypes and BD.4. Discussion
In the study presented, we conducted a family-based associa-
tion test examining the relationships between circadian gene SNP
Table 2
Haplotype-Based Association Test for CLOCK, ARNTL, and CSNK1E variants.
CLOCK
Haplotype Freq Families Z P P_2side Global P
h1: GACGCACGAA 0.409 105 0.756 0.449 0.446 0.162
h2: GAAACAACAG 0.253 101 1.043 0.297 0.238
h3: AGAGCGACCG 0.174 84 0.816 0.414 0.439
h4: GACGCGCGAA 0.085 45 0.434 0.664 0.709
h5: AGAGGGACCG 0.035 21 1.911 0.056 0.058
h6: AACGCACGAA 0.021 15 0.737 0.461 0.432
ARNTL
Haplotype Freq Families Z P P_2side Global P
h1: GGC 0.342 107 0.404 0.686 0.651 2.99E03
h2: GGA 0.267 95 2.419 1.56E02 1.48E02
h3: GAA 0.253 97 3.269 1.08E03 1.06E03
h4: AAA 0.137 73 1.06 0.289 0.304
CSNK1E
Haplotype Freq Families Z P P_2side Global P
h1: GGAG 0.718 112 0.61 0.542 0.519 5.91E03
h2: AGAA 0.206 91 2.829 4.67E-03 5.45E03
h3: AAGA 0.043 36 2.685 7.25E-03 7.62E03
h4: AGGA 0.029 38 0.316 0.752 0.840
884 individuals from 207 pedigrees were evaluated, using an additive model and biallelic tests. Haplotype¼ linkage disequilibrium blocks consisted on the following single-
nucleotide polymorphisms: CLOCK: rs10462028, rs1801260, rs3805148, rs3736544, rs17777927, rs11932595, rs4340844, rs4864542, rs2070062, and rs13132420; ARNTL:
rs1868049, rs3789327, and rs11022778; CSNK1E: rs2075983, rs1534891, rs6001093, and rs135757; Freq¼frequency of the haplotype; Families¼number of informative
families; P_2side¼two-sided p-values using permutation test based on 10,000 permutations. Bold denotes statistical signiﬁcance after Bonferroni correction for multiple
testing.
R. Gonzalez et al. / Journal of Affective Disorders 186 (2015) 367–375370markers and BD in a Latino sample. In our sample, we found
nominal associations with 4 SNPs and BD. Relationships between
BD and three of these four SNPs have been previously reported.
These include CSNK1E rs1534891, which has been reported as a
component of a multi-locus interaction associated with BD (Shi
et al., 2008), CSNK1D rs4510078, which has been associated with
BD (Kripke et al., 2009), and ARNTL rs3789327, which has been
associated with depression as a quantitative trait in BD (Maciu-
kiewicz et al., 2014). In addition, other SNPs located within the
haploblocks of interest have been associated with BD (Dmitrzak-
Weglarz et al., 2014; Shi et al., 2008; Soria et al., 2010) and other
clinical aspects of the illness including sleep disturbances
(Dmitrzak-Weglarz et al., 2014; Serretti et al., 2003, 2005), de-
pression (Maciukiewicz et al., 2014), appetite disturbances (Ma-
ciukiewicz et al., 2014), increased recurrence rates (Benedetti et al.,
2003), rapid cycling (Shi et al., 2008), and diurnal preference for
daily activities (Lee et al., 2010).
While the aforementioned SNP association did not demonstrate
signiﬁcant associations after corrections for multiple testing, the
analyses did identify a four-locus CSNK1E haplotype that was as-
sociated with BD. In addition, another four-locus CSNK1E haplo-
type was identiﬁed which was under-transmitted in BD. In ARNTL,
we also identiﬁed a 3-locus haplotype that was signiﬁcantly as-
sociated with BD as well as a second haplotype that was under-
transmitted in the illness. These ﬁndings suggest that some var-
iants in CSNK1E and ARNTL may confer increased susceptibility for
developing the disorder while others may provide a protective
effect against the development of the illness.
The central mechanism of molecular clocks revolves around the
expression of circadian genes and the interactions of their mRNA
and protein products that function as interconnected transcrip-
tional and translational feedback loops (Reppert and Weaver,
2002). The phase, period, and amplitude of endogenous clocks are
determined by the protein products of circadian genes. In essence,
the molecular clock is comprised of positive and negative arms
that function in a similar fashion to gears in a clock providing the
pushes and pulls that keep the clock ticking.Our ﬁndings are interesting in that the haplotypes found to be
in signiﬁcant association with BD were in two genes encoding
integral components of endogenous molecular clocks. ARNTL, lo-
cated on chromosome 11 (11p 15.2), encodes for a basic helix-
loop-helix-PAS domain transcription factor. Arntl forms a hetero-
dimer with Clock. It is this complex that makes up the positive arm
of the transcriptional–translational feedback loop. The Clock:Arntl
complex binds to E-box elements in promoter regions of other
core circadian genes such as the PER and CRY genes that comprise
the negative arm of molecular clocks. The timing of the en-
dogenous clock is able to be ﬁne tuned by certain clock modifying
factors. CSNK1E, located on chromosome 22 (22 q13.1), encodes
for a kinase which functions to phosphorylate clock proteins thus
affecting their function and stability (Reppert and Weaver, 2002).
Csnk1e phosphorylates the Per and Cry proteins, thus, regulating
the stability and subcellular localization of these core molecular
clock proteins (Akashi et al., 2002; Camacho et al., 2001; Keesler
et al., 2000; Lee et al., 2001; Schlosser et al., 2005). Phosphorylated
Per and Cry proteins are translocated back into the cytoplasm and
inhibit the transcriptional activity of Clock:Arntl. This causes a
decrease in the transcription of PER and CRY and decreases the
levels of these proteins thus resetting the molecular clock. The
functional role that Csnk1e exerts on the functioning of molecular
clocks (Vanselow and Kramer, 2007) may play a signiﬁcant role in
the expression of biological rhythms as well as the physiological
processes inﬂuenced by this system (Liu et al., 2007).
While possibly conferring risk for the development of rhythm
disturbances in BD, variations in these genes may have other
possible physiological consequences related to the illness. CSNK1E
has been associated with phenotypic variants of circadian phase
(Lowrey et al., 2000; Toh et al., 2001; Vanselow et al., 2006), do-
pamine regulation (Li et al., 2011), and a sensitivity to substances
of abuse (Bryant et al., 2012; Levran et al., 2008; Perreau-Lenz
et al., 2012; Veenstra-VanderWeele et al., 2006). These areas may
be germane to BD as phase disturbances (Linkowski et al., 1985a,
1985b, 1994; Nurnberger et al., 2000; Salvatore et al., 2008; Wehr
et al., 1980; Wood et al., 2009), substance abuse in BD (Levin and
Fig. 1. Casein kinase 1 epsilon (CSNK1E) haplotype block. A linkage disequilibrium plot of the CSNK1E gene (shown as a black line) and adjacent regions with respect to the
5 genotyped SNPs is presented. The data visualized here using Haploview V4.2 are based on the current genotyping data from the Latino population. Squares indicate pair-
wise r2 values on a red-scale with D′¼1 (red) through to D′¼0 (white). Linkage disequilibrium block, as deﬁned in Haploview, are represented by the triangular lines. The
nominally associated single marker rs1534891 is part of a 4-locus haploblock spanning 12 kilobases across introns 2–8. Order of haploblock SNPs (SNPs in bold) from left to
right: rs2075983; rs1534891; rs6001093; rs135757.
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have been related to the illness. In a similar fashion as with Clock,
Arntl forms heterodimer with Npas2. NPAS2, a paralog of CLOCK is
expressed in the forebrain, basal ganglia and limbic system (Reick
et al., 2001) and may play a role in processing sensory stimuli
(Dudley et al., 2003). ARTNL has also been associated with sea-
sonal affective disorder (Partonen and Lonnqvist, 1996) and me-
tabolic regulation (Gomez-Abellan et al., 2008; Kennaway et al.,
2013; Lee et al., 2011; Rudic et al., 2004; Shimba et al., 2011; Young
et al., 2014). These are of interest in bipolar disorder since sea-
sonality (Cassidy and Carroll, 2002; Hakkarainen et al., 2003; Shin
et al., 2005; Silverstone et al., 1995; Thompson et al., 1988), me-
tabolic abnormalities (Fagiolini et al., 2005), and cognitive dys-
function (Arts et al., 2008; Bora et al., 2009; Glahn et al., 2010)
have been associated with BD.
Some have suggested that examining the functioning of mo-
lecular clocks may yield advances in the phenotypic character-
ization of various illnesses (Saini et al., 2015). With respect to BD,
polymorphisms in circadian genes have demonstrated associations
with recurrence rates and cycling patterns (Benedetti et al., 2003;
Shi et al., 2008), insomnia (Serretti et al., 2003; Shi et al., 2008),
age at illness onset (Benedetti et al., 2004b), diurnal patterns ofmood expression (Shi et al., 2008), and response to treatments
such as sleep deprivation (Benedetti et al., 2004b) and lithium
(Benedetti et al., 2005). While bipolar disorder is a complex trait
disorder with evidence supporting a polygenic risk susceptibility
(Craddock and Sklar, 2013), variations in circadian genes may be
related to heritable phenotypic variants of the illness. These as-
sociations will need to be explored further to better characterize
possible phenotypes and heritable variants of the disorder.
Emerging literature suggests that certain pharmacological
treatments for bipolar disorder may affect functioning of mole-
cular clocks. Mood stabilizers such as lithium (Osland et al., 2011;
Padiath et al., 2004) and valproic acid (Johansson et al., 2011; Li
et al., 2002) have been shown to inﬂuence the rhythmic expres-
sion of circadian genes and the rhythmic properties of molecular
clocks. The effects of lithium on circadian gene may work to
modify functioning of the dopaminergic system (Roybal et al.,
2007). It has also been suggested that the rapid acting anti-
depressant response associated with both sleep deprivation and
low dose ketamine may be associated with the modulation of the
biological timing system (Benedetti et al., 2014; Bunney and
Bunney, 2013; Bunney et al., 2015). Ketamine has been shown to
alter circadian gene expression in neuronal cell culture (Bellet
Fig. 2. Aryl hydrocarbon receptor nuclear (ARNTL) haplotype blocks. The intermarker linkage disequilibrium pattern across the ARNTL gene (shown as a black line) was
generated by Haploview V4.2 based on 21 SNPs genotyped in the Latino population. Squares indicate pair-wise r2 values on a red-scale with D′¼1 (red) through to D′¼0
(white). Linkage disequilibrium blocks are represented by the triangular lines. The nominally associated single marker rs3789327 is part of a 3-locus haploblock (Block 5).
Major and minor alleles of Block 5 are in blue and red, respectively. Order of SNPs (haploblock SNPs in bold) from left to right: Block 1 (19 kb): rs2279285, rs2279284,
rs7107287, rs10766073, and rs7950226; Block 2 (14 kb): rs10832020, rs4757142, and rs11022762; Block 3 (5 kb): rs6486121, rs6486122; Block 4 (5 kb): rs1026071,
rs3816360, and rs7126303; Block 5 (7 kb): rs1868049, rs3789327, and rs11022778; Block 6 (7 kb): rs4757151, rs11022780, and rs10832030; Block 7 (4 kb): rs2290034,
rs2290034.
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gene expression in animal models (Thompson et al., 2010; Wisor
et al., 2002, 2008) and in humans (Ackermann et al., 2013; Archer
et al., 2008; Moller-Levet et al., 2013). It is hypothesized that these
rapid antidepressant effects may be secondary to resetting ab-
normalities in molecular clocks and therefore stabilizing circadian
rhythmicity (Bunney and Bunney, 2013; Bunney et al., 2015).
Our study has some strengths and some limitations. In terms of
testing for association at the genetic level, our analysis uses family
based association, which is robust to population stratiﬁcation
which can lead to false positive or negative results in genetic as-
sociation studies. Another strength of the study is that bipolar
patients were carefully diagnosed, using multiple sources of di-
agnostic information and a uniﬁed consensus approach and came
from families with high genetic loading for BD. The primary lim-
itation of the study is the sample size. Although the positive as-
sociation found is a signiﬁcant association, failure of association in
the other SNPs may be due to the small sample size and in-
sufﬁcient power to detect association of low to moderate effect
(OR 1.2–1.5). Larger samples would need to be studied within this
population to deﬁnitively rule out association between these other
genes and BD in Latinos.
In conclusion, the results of this family-based association study
of circadian genes and BD in a Latino population noted somenominal associations between circadian gene SNPs and statisti-
cally signiﬁcant associations between CSNK1E and ARNTL haplo-
types and BD. These ﬁndings support previous literature suggest-
ing that genetic variations in CSNK1E and ARNTL may confer an
increased susceptibility to the development of BD. It should be
noted that the current study focused solely on assessing the re-
lationships between SNPs and circadian genes and BD. Following
up these results using mapping and sequencing will be required to
deﬁne the genetic architecture of CSNK1E and ARNTL and any
speciﬁc variants “tagged” by this haplotype that might confer the
increased risk of BD in the Latino population. Replication of the
haplotype ﬁnding in Latino and non-Latino populations would be
useful to better understand the particular haplotype markers as-
sociated with BD in different populations. Future studies focusing
on intermediate phenotypes and examining quantitative traits are
warranted to deﬁne the functional role that CSNK1E and ARNTL
variations may play on the pathophysiology of BD. Given their
functioning, further research is warranted to ascertain the re-
lationships between circadian gene variants and physiological
mechanisms that may be related to BD.
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